OPPENHEIMER & CO INC - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 96 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
OPPENHEIMER & CO INC ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$544,900
+22.4%
20,0000.0%0.01%
+22.2%
Q2 2023$445,000
+2.7%
20,0000.0%0.01%0.0%
Q1 2023$433,200
+6.6%
20,0000.0%0.01%0.0%
Q4 2022$406,200
-20.8%
20,0000.0%0.01%
-25.0%
Q3 2022$513,000
+7.8%
20,0000.0%0.01%
+20.0%
Q2 2022$476,000
-3.8%
20,000
-9.1%
0.01%
+11.1%
Q1 2022$495,000
+25.6%
22,000
+10.0%
0.01%
+28.6%
Q3 2021$394,000
-10.5%
20,0000.0%0.01%
-12.5%
Q2 2021$440,000
+340.0%
20,0000.0%0.01%
+166.7%
Q4 2015$100,000
+33.3%
20,0000.0%0.00%
+50.0%
Q3 2015$75,00020,0000.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Consonance Capital Management LP 5,188,417$85,349,0007.80%
TANAKA CAPITAL MANAGEMENT INC 144,602$2,379,0005.69%
INGALLS & SNYDER LLC 6,817,540$112,149,0005.47%
NEXTHERA CAPITAL LP 1,045,196$17,193,0002.83%
Timpani Capital Management LLC 245,279$4,035,0001.41%
S&T BANK/PA 426,257$7,012,0001.25%
SHAKER INVESTMENTS LLC/OH 107,670$1,771,0001.10%
ESSEX INVESTMENT MANAGEMENT CO LLC 434,624$7,150,0000.94%
AMI ASSET MANAGEMENT CORP 709,300$11,668,0000.83%
Birchview Capital, LP 75,500$1,242,0000.82%
View complete list of CORCEPT THERAPEUTICS INC shareholders